An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection

Weill Cornell Medical College/New York Presbyterian Hospital, New York

Weill Cornell Medical College-Peds, New York

University of Pittsburgh Medical Center, Pittsburgh

Hospital of the University of Pennsylvania, Philadelphia

John Hopkins University School of Medicine, Baltimore

Duke University, Durham

Medical University of South Carolina, Charleston

St. Jude Children's Research Hospital, Memphis

Indiana Blood and Marrow Transplantation, Indianapolis

The Ohio State University Wexner Medical Center, Columbus

University of Minnesota, School of Medicine, Minneapolis

University of Chicago, Chicago

Washington University School of Medicine, St Louis

University of Kansas Cancer Center, Kansas City

University of Oklahoma, Oklahoma City

The University of Texas MD Anderson Cancer Center, Houston

City of Hope, Duarte

Children's Hospital of Orange County, Orange

Stanford University Medical Center, Palo Alto

Seattle Children's Hospital, Seattle

Brigham & Women's Hospital, Boston

Hackensack University Medical Center, Hackensack

Fred Hutchinson Cencer Research Center, Seattle